University of Warwick study finds no survival benefit of Bone Injections in Cardiac Arrest Treatment
The PARAMEDIC-3 trial, involving over 6,000 cardiac arrest patients, found no survival or recovery benefit from injecting life-saving drugs into the bone (intraosseous) compared to the traditional intravenous (IV) method. Conducted by the University of Warwick with NHS Ambulance Services, the study reaffirms IV as the standard, emphasizing the need for broader innovations in cardiac arrest care.
By EPN DeskUpdated








